Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EBMT 2020 | Mutation profile in CMML undergoing allo-HSCT

Nico Gagelmann • 1 Sep 2020
EBMT 2020
Leukemia

Nico Gagelmann, University Medical Center Hamburg-Eppendorf, Hamburg, Germany, discusses the impact of mutation profile in chronic myelomonocytic leukemia (CMML) undergoing allogeneic hematopoietic stem cell transplantation (allo-HSCT). This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

More from Nico Gagelmann

The efficacy of bispecific antibodies targeting BCMA or GPRC5D in relapsed myeloma after CAR-T
0:52
The efficacy of bispecific antibodies targeting BCMA or GPRC5D in relapsed myeloma after CAR-T
Nico Gagelmann • 7 Feb 2025
Investigating the outcomes and cellular dynamics of cilta-cel versus ide-cel in R/R myeloma
1:04
Investigating the outcomes and cellular dynamics of cilta-cel versus ide-cel in R/R myeloma
Nico Gagelmann • 7 Feb 2025
Addressing equity and equality in access to CAR-T in Europe
1:08
Addressing equity and equality in access to CAR-T in Europe
Nico Gagelmann • 7 Feb 2025
How CAR-T will impact the future of myeloma treatment
0:52
How CAR-T will impact the future of myeloma treatment
Nico Gagelmann • 15 Feb 2024

Related Videos

Unmet needs in CLL genomics: heterogeneity and clinical impact
1:11
Unmet needs in CLL genomics: heterogeneity and clinical impact
Elias Campo • 16 Oct 2026
Insights into key topics most likely to impact day-to-day CLL management
1:40
Insights into key topics most likely to impact day-to-day CLL management
Alessandra Ferrajoli • 16 Oct 2026
Translating current CLL evidence into national guidelines: which gaps remain?
3:33
Translating current CLL evidence into national guidelines: which gaps remain?
Mary Ann Anderson • 16 Oct 2026
Frontline management of Richter’s transformation: current approaches and remaining uncertainties
2:40
Frontline management of Richter’s transformation: current approaches and remaining uncertainties
Philip Thompson • 22 Oct 2026

Choose your cookie settings

VJHemOnc uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJHemOnc is intended for healthcare professionals